These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23846925)

  • 1. Advances in immunotherapy for pancreatic cancer: 2013.
    DeVito NC; Saif MW
    JOP; 2013 Jul; 14(4):347-53. PubMed ID: 23846925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic approaches to the management of pancreatic cancer.
    Laheru D; Biedrzycki B; Jaffee EM
    Cancer J; 2001; 7(4):324-37. PubMed ID: 11561608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer.
    Koido S; Homma S; Takahara A; Namiki Y; Komita H; Uchiyama K; Ito M; Gong J; Ohkusa T; Tajiri H
    Immunotherapy; 2012 Jan; 4(1):5-7. PubMed ID: 22149993
    [No Abstract]   [Full Text] [Related]  

  • 4. Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.
    Coveler AL; Rossi GR; Vahanian NN; Link C; Chiorean EG
    Immunotherapy; 2016 Feb; 8(2):117-25. PubMed ID: 26787078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Q&A: Evidence presenter. Interview by Marian Turner.
    Palucka K
    Nature; 2013 Dec; 504(7480):S9. PubMed ID: 24352364
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on NewLink's HyperAcute cancer immunotherapy products.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Jul; 8(7):847. PubMed ID: 23213663
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of vaccines for immunotherapy in pancreatic cancer.
    Plate J
    Expert Rev Vaccines; 2011 Jun; 10(6):825-36. PubMed ID: 21692703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for pancreatic cancer: present and future.
    Aroldi F; Zaniboni A
    Immunotherapy; 2017 Jun; 9(7):607-616. PubMed ID: 28595517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is recent in pancreatic cancer immunotherapy?
    Niccolai E; Prisco D; D'Elios MM; Amedei A
    Biomed Res Int; 2013; 2013():492372. PubMed ID: 23509731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for pancreatic cancer - science driving clinical progress.
    Laheru D; Jaffee EM
    Nat Rev Cancer; 2005 Jun; 5(6):459-67. PubMed ID: 15905855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application.
    Zheng R; Liu X; Zhang Y; Liu Y; Wang Y; Guo S; Jin X; Zhang J; Guan Y; Liu Y
    Front Immunol; 2024; 15():1383978. PubMed ID: 38756774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current topics and future to vaccine for pancreatic cancer].
    Miyazawa M; Yamaue H
    Nihon Jibiinkoka Gakkai Kaiho; 2013 May; 116(5):573-80. PubMed ID: 24024272
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential targets for pancreatic cancer immunotherapeutics.
    Dodson LF; Hawkins WG; Goedegebuure P
    Immunotherapy; 2011 Apr; 3(4):517-37. PubMed ID: 21463193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative treatments for pancreatic cancer.
    Lieberman SM; Hörig H; Kaufman HL
    Surg Clin North Am; 2001 Jun; 81(3):715-39. PubMed ID: 11459285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in therapeutic vaccines for pancreatic cancer.
    Plate JM
    Discov Med; 2012 Aug; 14(75):89-94. PubMed ID: 22935205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xiao-Zhong G; Qi XS
    J Immunol Res; 2017; 2017():8282391. PubMed ID: 28265583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer: 1998 update.
    Yeo CJ
    J Am Coll Surg; 1998 Oct; 187(4):429-42. PubMed ID: 9783792
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adoptive immunotherapy for pancreatic cancer, using MUC1 specific CTL].
    Masaki Y; Oka M
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1679-80. PubMed ID: 8886044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to relieve immunosuppression in pancreatic cancer.
    Schnurr M; Duewell P; Bauer C; Rothenfusser S; Lauber K; Endres S; Kobold S
    Immunotherapy; 2015; 7(4):363-76. PubMed ID: 25917628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New directions in immunotherapy for malignant solid tumors].
    Okuno K; Sugiura F; Sukegawa Y; Inoue K
    Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.